The global lacrimal devices market is projected to experience steady growth, with sales estimated at USD 32.1 million in 2025 and expected to rise to USD 57.0 million by 2035. This growth reflects a compound annual growth rate (CAGR) of 5.9% during the forecast period between 2025 and 2035. The increasing adoption of procedures like dacryocystorhinostomy (DCR) and advancements in lacrimal duct stenting are driving demand for these devices in the healthcare sector.
Key Market Drivers
- Dacryocystorhinostomy (DCR) Procedure: DCR is a minimally invasive outpatient procedure with a high success rate of over 90% in reducing epiphora (excessive tearing). The procedure involves the placement of lacrimal duct stent tubes to prevent duct closure, and it has gained popularity due to its effectiveness and relatively low risk of complications.
- Increasing Prevalence of Lacrimal Disorders: As the prevalence of lacrimal system disorders such as dacryocystitis (inflammation of the lacrimal sac) and blocked tear ducts rises, the demand for lacrimal devices is increasing. These conditions often require surgical intervention, further driving market growth.
- Technological Advancements in Lacrimal Devices: Improvements in the design and materials of lacrimal duct stent tubes are making the procedure more effective and safer, improving patient outcomes and fostering greater adoption by healthcare professionals.
Applications and Benefits
Lacrimal duct stent tubes, which are placed within the lacrimal duct for a period of 6-8 weeks, help maintain duct patency and promote the healing process following DCR. This procedure improves patient satisfaction by alleviating symptoms of epiphora and significantly reducing the risk of recurrent lacrimal duct obstruction.
A Full Report Overview – https://www.futuremarketinsights.com/reports/lacrimal-devices-market
Future Outlook
As DCR continues to gain recognition as a highly effective treatment for lacrimal duct obstructions, the lacrimal devices market is expected to grow steadily. Continued innovation in lacrimal devices and improved procedural outcomes will contribute to the ongoing expansion of the market.
Key Takeaways:
- The global lacrimal devices market is projected to grow from USD 30.4 million in 2024 to USD 57.0 million by 2035, at a CAGR of 5.9%.
- The dacryocystorhinostomy (DCR) procedure, with its high success rate and low risk of complications, is driving demand for lacrimal devices.
- Increasing prevalence of lacrimal disorders and technological advancements in stent tubes are contributing to market growth.
- The effectiveness of lacrimal devices in reducing epiphora and improving patient outcomes will continue to fuel market expansion.
Overview of Lacrimal Devices
Lacrimal devices, including lacrimal duct stent tubes, are primarily used in procedures like dacryocystorhinostomy (DCR) to treat conditions related to the lacrimal drainage system. DCR is a minimally invasive outpatient procedure that has a high success rate of over 90% in reducing epiphora (excessive tearing) when stenting is utilized.
Growth Drivers
- Increasing Incidence of Eye Disorders:
- The rising prevalence of eye-related conditions, particularly those affecting the lacrimal system, is driving demand for effective treatment options, including lacrimal devices.
- Technological Advancements:
- Innovations in lacrimal device technology improve the efficacy and safety of procedures, encouraging more healthcare providers to adopt these devices.
- Awareness and Compliance:
- Enhanced awareness among healthcare professionals and patients regarding the benefits of timely intervention for lacrimal drainage issues contributes to market growth.
- Aging Population:
- An increasing geriatric population, who are more susceptible to eye disorders, further drives the demand for lacrimal devices.
Regional Insights
- North America: Expected to dominate the market due to advanced healthcare infrastructure and a high prevalence of eye disorders.
- Asia-Pacific: Anticipated to witness significant growth driven by rising healthcare investments and an increasing patient population requiring ophthalmic care.
Key Players of Lacrimal Devices Market
- FCI Ophthalmics
- Kaneka Corporation (Kaneka Pharma America LLC)
- Gunther Weiss Scientific Glass
- Bess Medizintechnik GmBH
Key Segments of Lacrimal Devices Market
By Product:
In terms of product, the industry is divided into- monocanalicular lacrimal duct stent tube and bicanalicular lacrimal duct stent tube
By End User:
In terms of end user, the industry is segregated into hospitals, ophthalmic clinics and ambulatory surgical centers
By Region:
Key countries of North America, Latin America, Western Europe, Eastern Europe, South Asia and Pacific, East Asia and Middle East and Africa (MEA) have been covered in the report.
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube